Bioactivity:

Nortrachelogenin is a novel agent for prostate cancer therapy with ability to inhibit Akt membrane localization and activity as well as the activation of growth factor receptors, thereby efficiently synergizing with tumor necrosis factor-related apoptosis

CAS nr:

34444-37-6

Purity:

98%

Molecular Weight:

374,4

SMILES:

COc1cc(C[C@H]2COC(=O)[C@]2(O)Cc2ccc(O)c(OC)c2)ccc1O

Formula:

C20H22O7

Pathway:

Immunology/Inflammation,Immunology/Inflammation,Apoptosis,Proteases/Proteasome,Apoptosis,Proteases/Proteasome,Microbiology/Virology,GPCR/G Protein,Immunology/Inflammation,Cytoskeletal Signaling,PI3K/Akt/mTOR signaling,NF-_b,Neuroscience,Immunology/Inflammation,Tyrosine Kinase/Adaptors,Microbiology/Virology,Immunology/Inflammation

Target:

NOS,ROS,TNF,Caspase,Caspase,HIV Protease,HIV Protease,Prostaglandin Receptor,Prostaglandin Receptor,Akt,Akt,NF-_B,COX,COX,IGF-1R,Antifection,IL Receptor